TMCI Treace Medical Concepts, Inc.
Treace Medical Concepts, Inc. (TMCI) is expected to report earnings on November 6, 2026, before the market open. The consensus earnings estimate is a loss of $0.25 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -6.6% since its last earnings release on August 7, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Treace Medical Concepts, Inc.
Treace Medical Concepts is a commercial-stage orthopaedic medical device company with the goal of advancing the standard of care for the surgical management of bunion deformities.
Sector
Healthcare
Industry
Medical Appliances/Equipment